GMAB:NASDAQ
Genmab A/S - ADR
35,58 $
arrow_upward
+0,03%(+0,010) 1D
30 սեպ, 09:31:39 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
35,78 $
High
35,78 $
Low
35,48 $
Mkt. cap
22,03 մլրդ
Avg. vol.
2,39 մլն
Volume
12,62 հզր
P/E ratio
28,04
52-wk high
35,78 $
52-wk low
23,62 $
EPS
1,27 $
Beta
0,84
Shares outstanding
624,06 մլն
No. of employees
3 հզր
Open
35,78 $
High
35,78 $
Low
35,48 $
Mkt. cap
22,03 մլրդ
Avg. vol.
2,39 մլն
Volume
12,62 հզր
P/E ratio
28,04
52-wk high
35,78 $
52-wk low
23,62 $
EPS
1,27 $
Beta
0,84
Shares outstanding
624,06 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
21 րոպե առաջ
MRUS stock ends after Genmab completes its acquisition
AD HOC NEWS
·
1 օր առաջ
Genmab stock reflects higher 2026 revenue guidance
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3,12 հզր
Founded11 հնս, 1998 թ.
Headquarters-
Sector-
Websitegenmab.com